A newly published study reports that APC-deficient cancer cells may depend on a single metabolic enzyme for survival, ...

Nivolumab plus AVD is now FDA-approved for previously untreated Stage III or IV classical Hodgkin lymphoma in patients aged 12 years and older.

A new perspective article （Levkina, Vermonden et al.）argues that answering five fundamental questions about ferroptosis, an iron-dependent form of ...

Bristol Myers Squibb transforms the classical Hodgkin lymphoma treatment paradigm with expanded US & EMA approvals for Opdivo: Princeton, New Jersey Monday, March 23, 2026, 17:00 ...

With over 7 million people over 65 battling the degenerative disease — and the number expected to almost double by 2050 — new ...

UCLA researchers have uncovered a hidden weakness in some of the deadliest cancers, revealing a potential new strategy for ...

Every minute, nearly 500 antibiotic prescriptions are written in the U.S. Many of these drugs succeed, but more are being ...

In its early days, the AI initiative known as Project Maven had its fair share of skeptics at the Pentagon. Today, many of ...

Scientists have discovered that stressed cancer cells can pause their rapid growth and use a biological recycling trick to stay alive, challenging long-held beliefs about how aggressive cancers behave ...